Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Combat Meth Enhancement looks likely

This article was originally published in The Tan Sheet

Executive Summary

Congressional staff expect the Combat Methamphetamine Enhancement Act to pass after the Senate and House agree to "minor technical corrections" in the legislation that requires retailers to comply with provisions of the Combat Methamphetamine Epidemic Act of 2006. Minor changes in the House bill passed Sept. 22 include tweaking phrasing, statutory citations, adding a statement to comply with the PAYGO Act and replacing 2009 with 2010 in the title. A Feinstein staffer said Senate members likely will approve the House version the week of Sept. 27. The bill requires retailers to self-certify compliance with Drug Enforcement Administration regulations concerning Combat Met Act retail sales provisions. It sets $5,000 penalties for noncompliance and prohibits distributors from delivering pseuodephedrine-containing OTCs to noncompliant stores. The Consumer Healthcare Products Association and the National Association of Chain Drugstores support the measure, which enhances regulations limiting sales of PSE without creating new restrictions on consumer access to the drugs (1"The Tan Sheet" Aug. 2, 2010, In Brief)

You may also be interested in...



Congress, Missouri Enhance Meth Enforcement

Efforts to further tighten controls on sales of OTC methamphetamine precursors get a boost nationwide from Congress and in Missouri from a state law

Energy and Commerce clears meth bill

The House Energy and Commerce Committee July 28 passes the Combat Methamphetamine Enhancement Act of 2009, H.R. 2923. The bill, which cleared the Energy and Commerce Subcommittee on Health days earlier, would require retailers of nonprescription pseudoephedrine products to self-certify compliance with existing Combat Meth regulations (1"The Tan Sheet" July 26, 2010). The legislation, which the Senate passed in S. 256 in June 2009, is expected to become law with support from both sides of the aisle and OTC and drug store trade groups

QUOTED. 23 January 2020. John Milad.

Quanta Dialysis is linking up with B. Braun Avitum UK to support patients with Quanta’s personal hemodialysis device in the home. See what Quanta CEO John Milad said about it here.

Topics

UsernamePublicRestriction

Register

PS104532

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel